Published in HPB (Oxford) on July 22, 2013
Repeat hepatic resection in patients with colorectal liver metastases. World J Gastroenterol (2015) 0.79
Recurrence after hepatic resection in colorectal cancer liver metastasis -Review article-. J Med Life (2015) 0.79
Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg (2008) 4.86
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg (2009) 3.15
Left hepatic trisegmentectomy. Surg Gynecol Obstet (1982) 2.16
Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg (2004) 2.01
Right hepatic trisectionectomy for hepatobiliary diseases: results and an appraisal of its current role. Ann Surg (2007) 1.62
Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decision-making. Surg Oncol (2008) 1.58
Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis. J Gastrointest Surg (2009) 1.41
Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg (2007) 1.07
Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases. Ann Surg (2010) 1.02
Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. Ann Surg (2005) 1.01
Left hepatic trisectionectomy for hepatobiliary malignancies. J Am Coll Surg (2006) 0.99
Extended left hepatectomy: technical aspects of an evolving procedure. Br J Surg (1993) 0.98
Repeat liver resection for recurrent liver metastases from colorectal cancer. Eur J Surg Oncol (2006) 0.97
[Excision of the right lobe of the liver for a malignant secondary tumor]. Arch Mal Appar Dig Mal Nutr (1952) 0.95
Management of hepatic metastasis from colorectal cancers: an update. J Hepatobiliary Pancreat Surg (2008) 0.95
Prognostic factors of survival in repeat liver resection for recurrent colorectal metastases: review of sixty-two cases treated at a single institution. Dis Colon Rectum (2009) 0.94
A second liver resection due to recurrent colorectal liver metastases. Arch Surg (2007) 0.93
Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford) (2011) 0.93
Improved survival following right trisectionectomy with caudate lobectomy without operative mortality: surgical treatment for hilar cholangiocarcinoma. J Gastrointest Surg (2008) 0.91
Extended left hepatectomy. World J Surg (1999) 0.89
Outcome following repeat liver resection for colorectal liver metastases. Eur J Surg Oncol (2007) 0.88
In-contiguity and non-anatomical extension of right hepatic trisectionectomy for liver metastases. Br J Surg (2005) 0.87
Systematic review on safety and efficacy of repeat hepatectomy for recurrent liver metastases from colorectal carcinoma. Ann Surg Oncol (2007) 0.86
Single and multiple resections of multiple hepatic metastases of colorectal origin. Surgery (2004) 0.85
Short- and long-term results of extended left hepatectomy for colorectal metastases. HPB (Oxford) (2011) 0.81
Assessment of hepatic reserve for the indication of hepatic resection: how I do it. J Hepatobiliary Pancreat Surg (2005) 0.78
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol (2008) 1.64
Right hepatic trisectionectomy for hepatobiliary diseases: results and an appraisal of its current role. Ann Surg (2007) 1.62
Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations. Liver Transpl (2011) 1.52
Hepatic resection and transplantation for primary carcinoid tumors of the liver. Ann Surg (2004) 1.49
Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg (2010) 1.45
Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl (2004) 1.45
The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound (2003) 1.43
A simple prophylaxis regimen for MRSA: its impact on the incidence of infection in patients undergoing liver resection. Ann R Coll Surg Engl (2009) 1.42
Outcomes in right liver lobe transplantation: a matched pair analysis. Transpl Int (2008) 1.40
Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg (2007) 1.35
Surgical strategy for cystic diseases of the liver in a western hepatobiliary center. World J Surg (2002) 1.28
Liver transplantation following donation after cardiac death: an analysis using matched pairs. Liver Transpl (2009) 1.13
Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology (2005) 1.09
Inferior vena cava resection with hepatectomy: challenging but justified. HPB (Oxford) (2011) 1.06
Hemoperitoneum secondary to rupture of cystic artery pseudoaneurysm. Hepatobiliary Pancreat Dis Int (2007) 1.04
Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience. Transplantation (2009) 1.04
Outcomes after major hepatectomy in elderly patients. J Am Coll Surg (2006) 1.03
Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. Ann Surg (2005) 1.01
Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol (2008) 0.99
Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. J Hepatobiliary Pancreat Sci (2009) 0.99
Bile duct strictures after hepatobiliary surgery: assessment with MR cholangiography. Radiology (2004) 0.98
Treatment and surveillance of polypoid lesions of the gallbladder in the United Kingdom. HPB (Oxford) (2012) 0.97
Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging--comparison of optimized sequences. Radiology (2003) 0.97
Index admission laparoscopic cholecystectomy for patients with acute biliary symptoms: results from a specialist centre. HPB (Oxford) (2010) 0.96
Patient views through the keyhole: new perspectives on single-incision vs. multiport laparoscopic cholecystectomy. HPB (Oxford) (2012) 0.94
Indication for treatment and long-term outcome of focal nodular hyperplasia. HPB (Oxford) (2007) 0.94
The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases. Gastroenterology (2003) 0.94
Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. Liver Transpl (2013) 0.93
Hepatocellular carcinoma within a noncirrhotic, nonfibrotic, seronegative liver: surgical approaches and outcomes. J Am Coll Surg (2011) 0.91
Portal vein arterialization as a salvage procedure during left hepatic trisectionectomy for hilar cholangiocarcinoma. J Am Coll Surg (2008) 0.90
Prognostic utility of postoperative C-reactive protein for posthepatectomy liver failure. Arch Surg (2008) 0.89
Large hepatocellular carcinoma: time to stop preoperative biopsy. J Am Coll Surg (2007) 0.89
Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases. HPB (Oxford) (2010) 0.88
Predictors of blood transfusion requirement in elective liver resection. HPB (Oxford) (2010) 0.88
Metabonomics: a useful tool for the future surgeon. J Surg Res (2009) 0.88
Kinetics of liver function tests after a hepatectomy for colorectal liver metastases predict post-operative liver failure as defined by the International Study Group for Liver Surgery. HPB (Oxford) (2012) 0.88
Xanthogranulomatous cholecystitis: a European and global perspective. HPB (Oxford) (2013) 0.87
Acceptable outcome after kidney transplantation using "expanded criteria donor" grafts. Transplantation (2010) 0.87
One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach. Ann Surg (2014) 0.87
Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion. HPB (Oxford) (2011) 0.86
Total laparoscopic pancreaticoduodenectomy and reconstruction for a cholangiocarcinoma of the bile duct. J Laparoendosc Adv Surg Tech A (2007) 0.84
Identification and use of the putative Bacteroides ovatus xylanase promoter for the inducible production of recombinant human proteins. Microbiology (2008) 0.84
Subtotal hepatectomy and whole graft auxiliary transplantation for acetaminophen-associated acute liver failure. HPB (Oxford) (2013) 0.84
A combined liver-pancreas en-bloc transplant in a patient with cystic fibrosis. Transplantation (2005) 0.84
Ischemia- reperfusion injury and its influence on the epigenetic modification of the donor kidney genome. Transplantation (2008) 0.84
A cost effective analysis of a laparoscopic versus an open left lateral sectionectomy in a liver transplant unit. HPB (Oxford) (2014) 0.83
Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1. Inflamm Bowel Dis (2010) 0.83
Operative terminology and post-operative management approaches applied to hepatic surgery: Trainee perspectives. World J Gastrointest Surg (2013) 0.83
Laparoscopic left lateral sectionectomy: surgical technique and our results from Leeds. J Laparoendosc Adv Surg Tech A (2009) 0.83
Role of quantification of hepatic steatosis and future remnant volume in predicting hepatic dysfunction and complications after liver resection for colorectal metastases: a pilot study. HPB (Oxford) (2012) 0.82
Hepatic resection for colorectal metastasis: impact of tumour size. Ann Surg Oncol (2006) 0.82